FDA Approved Biologics: Can Etanercept and Ustekinumab be Considered a First-Line Systemic Therapy for Pediatric/Adolescents in Moderate to Severe Psoriasis? A Systematic Review

Psoriasis is a chronic immune-mediated skin disorder. Due to lack of clarity in its pathogenesis, a cure with existing treatment is a big challenge. Biologics, a revolutionary treatment, are potent immunomodulators that explicitly target the culprit cells of the immune system to achieve the maximum...

Descripción completa

Detalles Bibliográficos
Autores principales: Aslam, Nida, Saleem, Hajra, Murtazaliev, Salikh, Quazi, Sohail J, Khan, Safeera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494414/
https://www.ncbi.nlm.nih.gov/pubmed/32953323
http://dx.doi.org/10.7759/cureus.9812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494414/
https://www.ncbi.nlm.nih.gov/pubmed/32953323
http://dx.doi.org/10.7759/cureus.9812

Ejemplares similares